Acumed Pharmaceuticals Inc entered the industry of Noncommercial Biotechnical Research in 2004 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 541720, which describes it as a Noncommercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Noncommercial Biotechnical Research. The business provides service to the B2B market.
To acquire more information, please contact Marc E Lanser by calling No number given during business hours. You can also write to the business’ Single Location at 20 Newbury St # 5, Boston, Massachusetts MA 02116. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Acumed Pharmaceuticals Inc |
| Representative: | Marc E Lanser |
| Place of Business: | 20 Newbury St # 5, Boston, MA 02116 |
| Contact Number: | No number given |
| Type of Service: | Noncommercial Biotechnical Research |
| SIC Number: | 8733 |
| NAICS Number: | 541720 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2004 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Acumed Pharmaceuticals Inc is a company operating from Suffolk, Massachusetts providing professional Noncommercial Biotechnical Research and relevant B2B variables. It was founded in 2004 and registered with the SIC code 8733 as Noncommercial Biotechnical Research, and with the NAICS code 541720 as Noncommercial Biotechnical Research.
With a current employee count of 1 to 4, Acumed Pharmaceuticals Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Marc E Lanser at No number given for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 20 Newbury St # 5 in Boston, Massachusetts 02116 and can be engaged online through the company website at , the company Twitter , and Facebook page .